Beyond Borders: Ernst & Young’s Global Biotechnology Report 2007

Beyond Borders: Ernst & Young’s Global Biotechnology Report 2007: "Beyond Borders: Ernst & Young's Global Biotechnology Report 2007 From the Ernst & Young Global Biotechnology Center Success and Growth Bring Their Own Challenges At 31-years old, biotechnology has reached a point where it has 'come of age' and now it's on to the maturing years. We've seen evidence of strengthening pipelines, revenue growth, and progress towards profitability. This is often when challenges emerge that are the result of success. Challenges born from the convergence in time of innovative new products, newly profitable companies, and escalating regulatory challenges. Reflecting on 2006, Looking Ahead for 2007. In this year’s 'Beyond Borders' report, biotech and pharmaceuticals executives and global financial experts analyze the economic motivation, political environment, and cultural diversity that shaped record-breaking revenue and investment numbers around the world in 2006. Regional Reporting. See articles available now for a taste of the in-depth reporting and opinions that can help executives, analysts, and investors better understand an industry that’s becoming a regulation minefield while at the same time offering spectacular rewards to those who can successfully navigate the field. Commercialization Trends, Deal Making, and CEO Survey Results. Highlights from "